Fortress Biotech- 9.375% PRF PERPETUAL USD 25 - Ser A OverviewFortress Biotech- 9.375% PRF PERPETUAL USD 25 - Ser A Total Revenue
Revenue analysis for FBIOP.
Quarterly Revenue
$15.92M
↑ 21.17% YoY
As of Mar 2026
Annual Revenue (TTM)
$65.42M
↑ 13.3% YoY
Trailing 12 months ending Mar 2026
Average Revenue (Comparison Companies)
Total Revenue History
Total Revenue Comparison
Annual Revenue Growth Rate (%)
Annual Revenue Growth (Absolute)